Vijaya Diagnostic Centre Limited
National Stock Exchange of IndiaTotal Valuation
Vijaya Diagnostic Centre Limited carries a market capitalization of 131.89B, placing it among publicly traded companies globally. Its enterprise value stands at 101.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 131.89B |
| Enterprise Value | 101.16B |
Valuation Ratios
Vijaya Diagnostic Centre Limited trades at a trailing price-to-earnings ratio of 67.16.
| PE Ratio | 67.16 |
| PS Ratio | 14.18 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Vijaya Diagnostic Centre Limited trades at an EV/EBITDA multiple of 48.02 and an EV/FCF ratio of 487.86. The EV/Sales ratio of 14.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 48.02 provides insight into valuation relative to core operating earnings.
| EV / Sales | 14.18 |
| EV / EBITDA | 48.02 |
| EV / EBIT | 48.02 |
| EV / FCF | 487.86 |
Financial Position
Vijaya Diagnostic Centre Limited maintains a current ratio of 4.25, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.05, indicating elevated leverage, while an interest coverage ratio of 7.53 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 4.25 |
| Quick Ratio | 3.88 |
| Debt / Equity | 80.05 |
| Debt / EBITDA | N/A |
| Interest Coverage | 7.53 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 64.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Vijaya Diagnostic Centre Limited has paid 525.92M in income taxes, reflecting an effective tax rate of 25.85.
| Income Tax | 525.92M |
| Effective Tax Rate | 25.85 |
Stock Price Statistics
Vijaya Diagnostic Centre Limited's stock has gained approximately 33.3368% over the past 52 weeks. The 50-day moving average sits at 1,108.01, while the 200-day moving average is 1,030.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | 33.3368% |
| 50-Day Moving Average | 1,108.01 |
| 200-Day Moving Average | 1,030.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Vijaya Diagnostic Centre Limited generated 7.13B in revenue and converted that into 1.51B in net income, yielding earnings per share of 14.66. EBITDA reached 2.11B, while operating income came in at 2.11B.
| Revenue | 7.13B |
| Gross Profit | 6.26B |
| Operating Income | 2.11B |
| Pretax Income | 2.03B |
| Net Income | 1.51B |
| EBITDA | 2.11B |
| EBIT | 2.11B |
| Earnings Per Share (EPS) | 14.66 |
Margins
Vijaya Diagnostic Centre Limited operates with a gross margin of 87.74, reflecting its pricing power and cost economics. The operating margin of 29.54 and net profit margin of 21.12 provide insight into operational efficiency.
| Gross Margin | 87.74 |
| Operating Margin | 29.54 |
| Pretax Margin | 28.53 |
| Profit Margin | 21.12 |
| EBITDA Margin | 29.54 |
Scores
Vijaya Diagnostic Centre Limited posts an Altman Z-Score of 31.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 31.72 |